Russell Alan J: insider trades.
Russell Alan J reported 9 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($8.1M), across 1 company.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Russell Alan J
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Director, Officer · Chief Scientific Officer | 9 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 3,238 | $43.68 | 34,129 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | M | 7,031 | $0 | 37,367 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | M | 5,781 | $0 | 30,336 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 390 | $44.46 | 31,466 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 2,273 | $43.68 | 31,856 | Form 4 |
| 2026-07-01 | Edgewise Therapeutics, Inc. | S | 69,648 | $39.41 | 24,555 | Form 4 |
| 2026-07-01 | Edgewise Therapeutics, Inc. | M | 69,648 | $0.18 | 224,555 | Form 4 |
| 2026-07-01 | Edgewise Therapeutics, Inc. | M | 130,352 | $0.45 | 154,907 | Form 4 |
| 2026-07-01 | Edgewise Therapeutics, Inc. | S | 130,352 | $39.41 | 94,203 | Form 4 |
Questions
What stock did Russell Alan J buy or sell?
Russell Alan J reported 9 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($8.1M), across 1 company.
Is Russell Alan J the same person as other filers with this name?
This page covers SEC CIK 1853529 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/russell-alan-j-1853529.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.